adalimumab 40 MG per 0.4 ML Prefilled Syringe
- RxCUI
- 1726844
- RxNorm name
- adalimumab 40 MG per 0.4 ML Prefilled Syringe
- Display name
- adalimumab 40 MG per 0.4 ML Prefilled Syringe
- Full name
- adalimumab 40 MG per 0.4 ML Prefilled Syringe
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:00
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125057 | Humira | adalimumab | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Humira | ADALIMUMAB | Cordavis Limited | 4977567e-3525-44ac-9ff5-f1e74b053950 | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | 1726844 |
| Humira | ADALIMUMAB | AbbVie Inc. | 608d4f0d-b19f-46d3-749a-7159aa5f933d | 2025-12-23 | Boxed warning, Warnings, Adverse reactions | 1726844 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 608d4f0d-b19f-46d3-749a-7159aa5f933d | adalimumab 40 MG in 0.4 ML Prefilled Syringe [PSN] · 0.4 ML adalimumab 100 MG/ML Prefilled Syringe [SCD] · adalimumab 40 MG per 0.4 ML Prefilled Syringe [SY] | 3 | 2154 | These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA. HUMIRA ® (adalimumab) injection, for subcutaneous use Initial U.S. Approval: 2002 | 20251223 |
| 4977567e-3525-44ac-9ff5-f1e74b053950 | adalimumab 40 MG in 0.4 ML Prefilled Syringe [PSN] · 0.4 ML adalimumab 100 MG/ML Prefilled Syringe [SCD] · adalimumab 40 MG per 0.4 ML Prefilled Syringe [SY] | 3 | 4 | These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing information for HUMIRA. HUMIRA ® (adalimumab) injection, for subcutaneous use Initial U.S. Approval: 2002 | 20251223 |